Detalhe da pesquisa
1.
Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.
Am J Hematol;
92(10): E575-E583, 2017 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28699256
2.
Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.
Br J Haematol;
170(4): 496-503, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25921098
3.
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q).
Haematologica;
99(6): 1041-9, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24682512
4.
Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.
Eur J Haematol;
93(5): 429-38, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24813620
5.
First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors.
Clin Cancer Res;
30(3): 506-521, 2024 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37971712
6.
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
Blood;
118(14): 3765-76, 2011 Oct 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21753188
7.
The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project.
Oncologist;
22(12): 1415-1418, 2017 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28798271
8.
Polyps with advanced neoplasia are smaller in the right than in the left colon: implications for colorectal cancer screening.
Clin Gastroenterol Hepatol;
10(12): 1395-1401.e2, 2012 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22835574
9.
Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13.
Blood;
114(3): 522-5, 2009 Jul 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19332768
10.
The distribution of cardiac diagnostic testing for acute coronary syndrome in the Brazilian healthcare system: A national geospatial evaluation of health access.
PLoS One;
14(1): e0210502, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30629670
11.
Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).
J Clin Oncol;
36(25): 2593-2602, 2018 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29975624
12.
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.
J Clin Oncol;
35(5): 552-560, 2017 Feb 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28029309
13.
Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.
J Clin Oncol;
31(29): 3688-95, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24002500
14.
Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone.
J Clin Oncol;
28(1): 132-5, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19901114